SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000899140-06-001369
Filing Date
2006-10-04
Accepted
2006-10-04 17:24:28
Documents
2
Effectiveness Date
2006-10-04

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT PURSUANT TO SECTION 14(A) t3427787a.txt DFAN14A 4236
2 SCHEDULE 13D/A - SEVENTH AMENDMENT t3427787b.txt EX-1 29207
  Complete submission text file 0000899140-06-001369.txt   35801
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: DFAN14A | Act: 34 | File No.: 000-04829 | Film No.: 061129200
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DFAN14A